Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population

Part of paid clinical trials in Rockford, Illinois.

Sponsor
University of Illinois at Chicago
Study ID
NCT07587151
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CGM plus telehealth — OTHER
    Participants will receive CGM supplies for 3 months plus 2 monthly telehealth appointments.
  • CGM only — OTHER
    Participants will receive CGM supplies for 3 months

Study Details

The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois. Our aim is to assess the feasibility and preliminary effectiveness of a pilot program combining continuous glucose monitoring (CGM) with monthly telehealth appointments to improve diabetes management in FQHC patients who have uncontrolled T2DM (HbA1c \>7%). Researchers will compare those who receive the intervention (usual in-person care + CGM + 2 telehealth visits with a clinical pharmacist and family medicine resident) with those receiving a CGM in additional to usual care (in-person care + CGM). Participants will have their HbA1c tested and complete surveys to assess diabetes-related distress and diabetes management self-efficacy at baseline and 3 and 6 months from baseline. This will allow the investigators to raise glucose awareness for all participants utilizing CGM technology while simultaneously determining the necessity of more frequent follow-up than the guideline recommended intervals of 3 months for uncontrolled diabetes in an under-resourced population. This will also allow us to evaluate the feasibility of telehealth in delivering more frequent follow-up care to patients with T2DM.

Key Dates

Start date
Mar 31, 2025
Status verified
May 2026
Primary completion
Dec 5, 2025
Completion
Apr 28, 2026

Study Design

Enrollment
46 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: CGM + telehealth
    In addition to usual care for patients with poorly controlled diabetes, participants will receive a CGM plus education on its use and 2 telehealth appointments, 1 month and 2 months from their initial appointment. The telehealth appointments will be conducted by a clinical pharmacist and family medicine resident physician and will be used to discuss CGM outcomes and treatment planning.
  • Active Comparator: CGM only
    In addition to usual care for patients with poorly controlled diabetes, participants will receive a CGM plus education on its use.

Primary Outcome Measure

HbA1c [ Time Frame: Enrollment, 3 months, and 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Illinois College of Medicine RockfordRockfordIllinois61107-

Find similar trials in Rockford, IL

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Illinois College of Medicine Rockford· Rockford, IL

Related Studies